Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
Ophthalmology (Rochester, Minn.), 2016-06, Vol.123 (6), p.1351 [Peer Reviewed Journal]Copyright © 2016 American Academy of Ophthalmology. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2016.02.022 ;PMID: 26935357
Digital Resources/Online E-Resources